| 2024-02-21 | Sale | Voyager Therapeutics, Inc. VYGR | Chief Financial Officer | 3,764 0.008% | $7.46 | $28,079 | +12.17% | |
| 2023-10-03 | Sale | Voyager Therapeutics, Inc. VYGR | Chief Financial Officer | 13,567 0.0298% | $6.99 | $94,833 | +10.99% | |
| 2020-10-15 | Sale | UroGen Pharma Ltd. URGN | Chief Financial Officer | 4,800 0.0211% | $21.77 | $104,496 | -18.52% | |
| 2020-09-01 | Sale | UroGen Pharma Ltd. URGN | Chief Financial Officer | 1,018 0.0025% | $11.41 | $11,615 | -9.36% | |
| 2020-07-27 | Sale | UroGen Pharma Ltd. URGN | Chief Financial Officer | 282 0.0006% | $11.76 | $3,315 | -16.68% | |
| 2020-05-20 | Sale | UroGen Pharma Ltd. URGN | Chief Financial Officer | 716 0.0017% | $12.54 | $8,975 | -14.5% | |
| 2020-04-27 | Sale | UroGen Pharma Ltd. URGN | Chief Financial Officer | 282 0.0013% | $24.35 | $6,867 | -10.43% | |
| 2020-02-20 | Sale | UroGen Pharma Ltd. URGN | Chief Financial Officer | 720 0.0033% | $29.68 | $21,370 | -24.89% | |
| 2020-01-27 | Sale | UroGen Pharma Ltd. URGN | Chief Financial Officer | 1,334 0.0066% | $29.28 | $39,060 | -18.3% | |
| 2019-11-20 | Sale | UroGen Pharma Ltd. URGN | Chief Financial Officer | 708 0.0032% | $28.41 | $20,114 | -18% | |
| 2019-08-20 | Sale | UroGen Pharma Ltd. URGN | Chief Financial Officer | 2,832 0.0138% | $33.07 | $93,654 | -20.94% |